Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay

Journal of Medical Virology

Volumn 80, Issue 4, 2008, Pages 603-606

  Alzahrani, Alhusain J ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Antibodies and core antigen; Drug users; ELISA; Hepatitis C virus

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; DIAMORPHINE; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; VIRUS RNA;

ADULT; ALCOHOLISM; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BLOOD SALVAGE; CANNABIS ADDICTION; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC VALUE; DRUG DEPENDENCE; HEPATITIS C; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HUMAN; IMMUNOASSAY; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; REHABILITATION CENTER; SAUDI ARABIA; SERODIAGNOSIS;

ADULT; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNOASSAY; MALE; RNA, VIRAL; SAUDI ARABIA; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 40549131904     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21075     Document Type: Article

References (19)

1. Alados-Arboledas JC, Calbo-Torrecillas L, Lopez-Prieto MD, de Francisco-Ramirez JL, de Miguel-Sastre C. 2007. Clinical assessment of Monolisa HCV Ag-Ab ULTRA (Bio-Rad) in a general hospital. Enferm Infecc Microbiol Clin 25:172-176.
2. Alzahrani AJ. 2005. Analysis of HCV core antigenemia in Saudi Drug users. Saudi Medic J 26:1645-1646.
3. Alzahrani AJ, Obeid OE. 2004. Detection of hepatitis C virus core antigen in blood donors usinga new enzyme immunoassay. FAMCO J 11:103-107.
4. Ansaldi F, Bruzzone B, Testino G, Bassetti M, Gasparini R, Crovari P, Icardi G. 2006. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. J Viral Hepat 3:5-10.
5. Barth H, Liang TJ, Baumert TF. 2006. Hepatitis C virus entry: Molecular biology and clinical implications. Hepatology 44:527-535.
6. Courouce AM, Le Marrec N, Bouchardeau F, Razer A, Maniez M, Laperche S, Simon N. 2000. Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion 40:1198-1202.
7. Fabrizi F, Lunghi G, Aucella F, Mangano S, Barbisoni F, Bisegna S, Vigilante D, Limido A, Martin P. 2005. Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol 43:414-420.
8. Fathalla S, Al-Jama A, Badawy M, Sabry H, Awad O, Abdul-Aziz F, Elnajar M. 2003. Prevalence of hepatitis C virus infection in the Eastern Province of Saudi Arabia DNA and second generation and supplemental EIA tests. Saudi Medic J 24:S120-S121.
9. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR. 2003. Acute hepatitis C: High rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125:80-88.
10. Laperche S, Le Marrec N, Girault A, Bouchardeau F, Servant-Delmas A, Maniez-Montreuil M, Gallian P, Levayer T, Morel P, Simon N. 2005. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J Clin Microbiol 43:3877-3883.
11. McHutchison JG, Bacon BR. 2005. Chronic hepatitis C: An age wave of disease burden. Am J Manag Care 11:S286-S295.
12. Murrill CS, Weeks H, Castrucci BC, Weinstock HS, Bell BP, Spruill C, Gwinn M. 2002. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health 92:385-387.
13. Njoh J, Zimmo S. 1997. Prevalence of antibodies to hepatitis C virus in drug-dependent patients in Jeddah, Saudi Arabia. East Afr Med J 74:89-91.
14. Pawlotsky JM. 2002. Use and interpretation of virological tests for hepatitis C. Hepatology 36:S65-S73.
15. Ramia S, Eid-Fares J. 2006. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis 10:272-277.
16. Santolamazza M, Delle Monache M, Alvino A, Bacosi M, D'Innocenzo S, Ciervo U, Antonaci A, Russo F, Miglioresi L, De Angelis A, Ursitti A, Ricci GL. 2001. Multiple viral infections in a group of intravenous drug users: Hepatitis B virus exposure is the risk factor. Eur J Gastroenterol Hepatol 13:1347-1354.
17. Schnuriger A, Dominguez S, Valantin MA, Tubiana R, Duvivier C, Ghosn J, Simon A, Katlama C, Thibault V. 2006. Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: Potential use for high-risk individuals. J Clin Microbiol 44:1561-1563.
18. Shawky S, Ghabrah TM, Abalkhail BA, Soliman NK. 2003. Hepatitis C infection among drug addicts. Saudi Medic J 24:S133-S133.
19. Takahashi M, Saito H, Higashimoto M, Atsukawa K, Ishii H. 2005. Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy. J Clin Microbiol 43:186-191.